GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (FRA:IX1) » Definitions » Long-Term Debt

IDEXX Laboratories (FRA:IX1) Long-Term Debt : €473 Mil (As of Sep. 2024)


View and export this data going back to 1991. Start your Free Trial

What is IDEXX Laboratories Long-Term Debt?

IDEXX Laboratories's Long-Term Debt for the quarter that ended in Sep. 2024 was €473 Mil.

IDEXX Laboratories's quarterly Long-Term Debt declined from Mar. 2024 (€571 Mil) to Jun. 2024 (€487 Mil) and declined from Jun. 2024 (€487 Mil) to Sep. 2024 (€473 Mil).

IDEXX Laboratories's annual Long-Term Debt declined from Dec. 2021 (€686 Mil) to Dec. 2022 (€656 Mil) and declined from Dec. 2022 (€656 Mil) to Dec. 2023 (€571 Mil).

IDEXX Laboratories Long-Term Debt Historical Data

The historical data trend for IDEXX Laboratories's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Long-Term Debt Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 629.02 705.68 686.06 655.50 571.18

IDEXX Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 579.83 571.18 571.12 487.49 472.81

IDEXX Laboratories  (FRA:IX1) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

IDEXX Laboratories Long-Term Debt Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEXX Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (FRA:IX1) » Definitions » Long-Term Debt
Comparable Companies
IQV A MTD ILMN WAT NTRA LH DGX ICLR RVTY TMO DHR XSWX:LONN SHSE:603259 XPAR:BIM MEDP CRL EXAS QGEN XPAR:ERF
Traded in Other Exchanges
IDXX:USA IDXX:Mexico 0J8P:UK IX1:Germany I1DX34:Brazil IDXX:Austria
Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Website
https://www.idexx.com
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

IDEXX Laboratories Headlines

No Headlines